Abstract
Simple and efficient procedures for palladium-catalyzed cross-coupling reactions of N-substituted 4-bromo-7-azaindole (1H-pyrrole[2,3-b]pyridine), with amides, amines, amino acid esters and phenols through C–N and C–O bond formation have been developed. The C–N cross-coupling reaction of amides, amines and amino acid esters takes place rapidly by using the combination of Xantphos, Cs2CO3, dioxane and palladium catalyst precursors Pd(OAc)2/Pd2(dba)3. The combination of Pd(OAc)2, Xantphos, K2CO3 and dioxane was found to be crucial for the C–O cross-coupling reaction. This is the first report on coupling of amides, amino acid esters and phenols with N-protected 4-bromo-7-azaindole derivatives.
Graphical Abstract
Introduction
Palladium-catalyzed C–N and C–O bond-forming reactions between 4-substituted 7-azaindoles and amides, amines, amino acid esters or phenols have recently gained popularity among the scientific community for different drug-discovery and -development programs. Particularly, several 7-azaindoles (1H-pyrrole[2,3-b]pyridine) [1-4], including 4-substituted compounds [5-8] have found applications in various therapeutic areas. Despite their utility in various drug-development programs in academic research and the pharmaceutical industry, methods for the synthesis of this class of compounds and functionalization of 7-azaindole scaffolds remain limited [9]. Although the literature enumerates various methods for the synthesis of substituted azaindole motifs, they are limited to N-1, C-2 or C-3 functionalized structures [5-8,10]. Furthermore, regioselective C–O-bond-forming reactions are interesting in organic synthesis due to the presence of these bonds in numerous natural products, biological compounds, pharmaceuticals, fragrances, cosmetics and polymers [11-17]. Among others Buchwald, Hartwing and co-workers followed by many other groups during the past decade reported the metal-catalyzed formation of carbon–heteroatom bonds [18-30]. Most of the literature reports are limited to aryl halides and indoles only. Clearly, each of these protocols has its own virtues; however, limitations still exist with respect to substrate scope, reagents and solvents, etc. Thus, palladium-catalyzed intra- and intermolecular cross-coupling reactions of azaindoles with amides, amines, amino acid esters or phenols offer an interesting complementary method for the synthesis of C–N and C–O bonds under comparably mild conditions. It is important to note that, in contrast to well-established palladium-catalyzed coupling reactions of indole with amines, alcohols and phenols [5,7,31-36], very few studies on the formation of C–N and C–O bond formation over 7-azaindole have been performed [37-39]. On the other hand, the chemistry of 4-bromo-7-azaindole has not been explored in depth until today.
Amino and phenyl-substituted 7-azaindole scaffolds appear in various pharmaceutically important molecules (Figure 1), which are very challenging and lengthy to prepare by the traditional methods [40,41]. In general, nucleophilic aromatic substitution (SNAr) reaction of a halo-precursor of 7-azaindole with a large excess of amine counterpart under high reaction temperatures, preferably under heating to more than 180 °C or through the use of microwave irradiation, results in the amino-7-azaindole in moderate to low yield [5,7]. Primary alkylamines or anilines under similar reaction conditions provided the displacement rearrangement products 4-amino-5-azaindole as the sole product [7]. Very recently Buchwald et al. [39] reported a palladium-catalyzed amination of unprotected halo-7-azaindoles using biarylphosphine ligands (DavePhos), palladium precatalyst (RuPhos)-based reagents, and LiHDMS as a base. However, inconsistency of the results was observed when the reactions were carried out on a large scale. As part of continuing efforts in our laboratory [42-46] toward the development of new and improved methods in organic synthesis, we became interested in the possibility of developing an efficient palladium-mediated coupling of amides, amines, amino acid esters and phenols with N-protected 7-azaindole derivatives for one of our medicinally important drug-development programs.
Figure 1: Representative drug candidates of amino-azaindole and phenyl-azaindole containing motifs.
Figure 1: Representative drug candidates of amino-azaindole and phenyl-azaindole containing motifs.
We herein report on Pd-catalyzed coupling reactions of N-protected 4-bromo-7-azaindoles with amides, amines, amino acid esters and phenols (Scheme 1), to yield new important intermediates for one of our medicinal chemistry programs. To the best of our knowledge this is the first report on intermolecular coupling of 4-bromo-7-azaindole with amides, amino acid esters and phenols.
Scheme 1: Cross coupling of 4-bromo-7-azaindole with amides, amines, amino acid esters and phenols.
Scheme 1: Cross coupling of 4-bromo-7-azaindole with amides, amines, amino acid esters and phenols.
Results and Discussion
4-Bromo-7-azaindole derivative 1 was prepared from 7-azaindole by the literature procedure [47]. In most of the cases we have used the N-protection of 4-bromo-7-azaindole. It is worth mentioning that 7-azaindole (1H-pyrrole[2,3-b]pyridine), has a [4.3]-bicyclic indene skeleton with a fused electron-rich pyrrole ring and an electron-deficient pyridine ring. The pKa value of 7-azaindole is ~4.9, and it undergoes self-association through hydrogen-bonding to form a dimer in solution and phototautomerizes by an excited-state double-proton-transfer (ESDPT) process [1,48]. In the presence of copper or palladium catalysts azaindole undergoes arylation of the heterocyclic N–H nitrogen [49,50]. To find a suitable condition for amide coupling with 7-azaindole derivatives, various biaryl/alkyl phosphine ligands, palladium catalysts, bases and reaction times, etc., were screened by using electron-deficient N-protected 4-bromo-7-azaindoles 1 as substrates (Table 1). N-Benzyl-4-bromo-7-azainole (1-benzyl-4-bromo-1H-pyrrolo[2,3-b]pyridine, 1e) and benzamide (2a) were chosen as model substrates to find the suitable palladium-mediated coupling of amides with N-protected 4-bromo-7-azaindole 1. After extensive screening, we found that the combination of Pd(OAc)2, Xantphos (L1) as a ligand [51-53], Cs2CO3 as a base and dioxane as a solvent provided the most successful result (Table 1, entry 1). The reaction temperature was maintained at ~100 °C in all cases. Switching the Pd source to Pd2(dba)3 resulted in a slight decrease in yield (Table 1, entry 2). Other available ligands, e.g., SPhos (L2) and XPhos (L3) provided lower yields when Pd2(dba)3 was used as a catalyst, even after longer reaction time (Table 1, entries 3 and 4). By using Pd(OAc)2 as a catalyst and SPhos (L2) and XPhos (L3) as a bidentate ligand, low to moderate yields were obtained (Table 1, entries 6 and 7). When tertiary ligand PCy3 (L4) was used as a ligand for the cross-coupling reaction no product formation was observed (Table, entry 5). Cross-coupling reaction of N-benzyl-4-bromo-7-azaindole (1e) and benzamide (2a) with other bases, e.g., K2CO3 and K3PO4, by using Pd(OAc)2 and Xantphos (L1) as a ligand provided good yield in 4 to 3 h (Table 1, entries 8 and 9). It is worth mentioning that Xantphos (L1) as a supporting ligand finds wide popularity in palladium-mediated amidation reactions by various research groups [54-56], which prompted us to evaluate the process further, with various substrate scopes.
Table 1: Reaction optimization for coupling of 1e with benzamide (2a) under various conditionsa.
|
|||||
Entry | Pd catalyst (5 mol %) | Ln | Base | Time (h) | Yield (%)b |
---|---|---|---|---|---|
1 | Pd(OAc)2c | L1 | Cs2CO3 | 2 | 95d |
2 | Pd2(dba)3 | L1 | Cs2CO3 | 5 | 90 |
3 | Pd2(dba)3 | L2 | Cs2CO3 | 24 | 40 |
4 | Pd2(dba)3 | L3 | Cs2CO3 | 24 | 40 |
5 | Pd2(dba)3 | L4 | Cs2CO3 | 24 | 0 |
6 | Pd(OAc)2 | L2 | Cs2CO3 | 24 | 45 |
7 | Pd(OAc)2 | L3 | Cs2CO3 | 24 | 61 |
8 | Pd(OAc)2 | L1 | K2CO3 | 4 | 83 |
9 | Pd(OAc)2 | L1 | K3PO4 | 3 | 88 |
aReactions of 1-benzyl-4-bromo-1H-pyrrolo[2,3-b]-pyridine (1e) (1.0 mmol) with benzamide (2a) (1.2 mmol) were performed in a sealed Schlenk tube at 100 °C in dioxane (2 mL) by using Pd catalyst (5 mol %), ligand (10 mol %) and base (1.5 mmol). bYields reported are isolated yields. cNo reaction occurred without palladium catalyst. dNo reaction occurred at room temperature.
With optimized conditions in hand, we embarked on an investigation of the reaction scope by subjecting various N-protected 7-azaindoles 1 to a wide range of amides 2. The experimental results are summarized in Table 2. The reaction did not proceed at all without N-protection (1a, Table 2, entry 1). When the reaction was carried out with N-sulfonyl-protected 4-bromo-7-azaindole 1b only the desulfonated product (Table 2, entry 2) was obtained. It is worth mentioning that the N-sulfonyl protected 7-azaindole 1b was efficiently deprotected under basic conditions in dioxane [57]. The optimized reaction conditions worked well with benzamide (2a) (Table 2, entry 3) and phenylsulfonamide (2b) (Table 2, entry 4) to obtained a good yield. A cyclic secondary amide (lactam) 2c also reacted efficiently (Table 2, entry 5). The methodology works equally well with 2-methoxybenzamide (2d) (Table 2, entry 6) and 4-fluorobenzamide (2e) (Table 2, entry 7). We checked the selectivity of amide and amine coupling by reacting N-ethyl-7-bromoazaindole (1d) with 2-aminobenzamide (2f) and obtained 2-amino-N-(1-ethyl-1H-pyrrolo[2,3-b]pyridin-4-yl)benzamide (3f) in 85% yield (Table 2, entry 8). We found that amide is more reactive than amine under the reaction conditions studied. The use of Cs2CO3 as the base is advantageous because the common functional groups such as fluoro, methoxy, etc., are well tolerated. We found that the N-protection of 4-bromo-7-azaindoles 1 has a marginal effect on the reaction yield and time. The coupling of amides with N-protected 4-bromo-7-azaindoles 1 was demonstrated in multi-gram synthesis in our hands. Next we diverted our attention towards coupling of N-protected 4-bromo-7-azaindoles 1 with amines 4.
Table 2: C–N-bond-formation cross coupling of N-protected 4-bromo-7-azaindoles 1 with amides 2.
|
|||||
Entry | 7-Azaindole 1 | Amide 2 | Product 3a | Time (h) | Yield (%)b |
---|---|---|---|---|---|
1 |
1a |
2a |
– | 24 | NRc |
2 |
1b |
2a |
– | 5 | 0d |
3 |
1c |
2a |
3a |
2 | 95 |
4 |
1c |
2b |
3b |
3 | 85 |
5 |
1c |
2c |
3c |
2.5 | 92 |
6 |
1d |
2d |
3d |
3 | 91 |
7 |
1d |
2e |
3e |
3 | 89 |
8 |
1d |
2f |
3f |
3 | 85 |
9 |
1e |
2a |
3g |
2 | 95 |
aReactions of N-protected 7-azaindoles 1 (1.0 mmol) with amides 2 (1.2 mmol) were performed in a sealed Schlenk tube at 100 °C in dioxane (2 mL) by using Pd(OAc)2 (5 mol %), Xantphos (10 mol %) and base (1.5 mmol). bYields reported are isolated yields. cNR no reaction. dDesulfonation reaction takes place.
Synthesis of 4-amino-7-azaindoles was generally achieved from the corresponding halide by SNAr displacement reactions, which typically require very high temperatures, extended reaction times, and a large excess of the amine counterpart [5]. Other alternative methods employ the amino-substituted azaindole as the key intermediate, which are challenging to prepare [6]. Initially, coupling of 4-bromo-1-ethyl-1H-pyrrolo[2,3-b]pyridine (1d) with phenylmethanamine (4a) was selected as a model reaction to optimize the reaction condition of C–N-bond formation of amines. The experimental results are summarized in Table 3. After the screening of various ligands (Scheme 1), palladium catalysts, and bases (Table 1), the catalyst combination of Pd2(dba)3, Xantphos and Cs2CO3 in dioxane was found to be crucial. The cross-coupling reaction of 4-bromo-1-ethyl-1H-pyrrolo[2,3-b]pyridine (1d) with phenylmethanamine (4a) proceeded rapidly by using the combination of Pd2(dba)3, Xantphos and Cs2CO3 in dioxane at 100 °C for 1 h (Table 3, entry 1). When K2CO3 was used as base along with Pd2(dba)3 as catalyst and XantPhos (L1) as ligand, slightly lower yield (~85%) was obtained (Table 3, entry 2) in 3 h. Other ligands SPhos (L2) and XPhos (L3) with Pd2(dba)3 as catalyst provided average yields of 60 and 62%, respectively, in 6 h (Table 3, entries 3 and 4). However, the tertiary phosphine ligand PCy3 (L4) was ineffective in generating any product (Table 3, entries 5 and 12). Interestingly, Pd(OAc)2 results in poor yields of the product (Table 3, entries 6–12). Given this surprising result, we hypothesized that the amination product 5 may interfere with catalyst turnover by promoting the formation of an inactive Pd-chelate complex.
Table 3: Optimization of the coupling reaction of 4-bromo-1-ethyl-1H-pyrrolo[2,3-b]pyridine (1d) with phenylmethanamine (4a).a
|
|||||
Entry | Pd-catalyst (5 mol %) | Ln | Base | Time (h) | Yield (%)b |
---|---|---|---|---|---|
1 | Pd2(dba)3 | L1 | Cs2CO3 | 1 | 93 |
2 | Pd2(dba)3 | L1 | K2CO3 | 3 | 85 |
3 | Pd2(dba)3 | L2 | Cs2CO3 | 6 | 60 |
4 | Pd2(dba)3 | L3 | Cs2CO3 | 6 | 62 |
5 | Pd2(dba)3 | L4 | Cs2CO3 | 24 | 0 |
6 | Pd(OAc)2 | L1 | Cs2CO3 | 24 | 20 |
7 | Pd(OAc)2 | L1 | K2CO3 | 24 | 15 |
8 | Pd(OAc)2 | L1 | NaOt-Bu | 24 | 23 |
9 | Pd(OAc)2 | L1 | K3PO4 | 24 | 20 |
10 | Pd(OAc)2 | L2 | Cs2CO3 | 24 | 18 |
11 | Pd(OAc)2 | L3 | Cs2CO3 | 24 | 17 |
12 | Pd(OAc)2 | L4 | Cs2CO3 | 24 | 0 |
aReactions of 1-ethyl-4-bromo-1H-pyrrolo[2,3-b]-pyridine (1d) (1.0 mmol) with phenylmethanamine (4a) (1.2 mmol) were performed in a sealed Schlenk tube at 100 °C in dioxane (2 mL) by using Pd catalyst (5 mol %), ligand (10 mol %) and base (1.5 mmol). bYields reported are isolated yield.
With a viable coupling procedure in hand, attention was turned to the generality of the process and couplings of structurally diverse nucleophilic amines. As seen from Table 4, the cross-coupling reaction of N-protected 4-bromo-7-azaindoles 1a–1d with various amines 4a–4f proved to be general under the optimized conditions to get the coupled products 5a–5f in very good yield (88–94%) within a reasonable time of 2.5 to 3 h. The C–N-bond-forming reaction of primary aromatic amines (Table 4, entries 3, 4 and 6) proceeded smoothly under the optimized conditions to provide excellent yields of the corresponding coupling products 5a, 5b and 5d, respectively. The reaction was also effective for cyclic amine morpholine (Table 4, entry 5) and Boc-protected piperazine (Table 4, entry 8). The reaction works equally well for aliphatic primary amine too (Table 4, entry 7) resulting in 90% isolated yield. There was a feeble change in yield by varying the substitution on the 7-azaindole nitrogen (N1) from a methyl to an ethyl group (Table 4, entries 6–8). There was no reaction without the N-protection (Table 4, entry 1). Heating of the reaction mixture of 4-bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine (1b) with phenylmethanamine (4a) in the presence of base and palladium catalyst resulted in the desulfonated 4-bromo-7-azaindole as the sole product (Table 4, entry 2).
Table 4: C–N-bond-formation cross coupling of N-protected 4-bromo-7-azaindoles 1 with amines 4.
|
|||||
Entry | 7-Azaindole 1 | Amine 4 | Product 5a | Time (h) | Yield (%)b |
---|---|---|---|---|---|
1 |
1a |
4a |
– | 24 | NRc |
2 |
1b |
4a |
– | 3 | 0d |
3 |
1c |
4a |
5a |
2.5 | 92 |
4 |
1c |
4b |
5b |
3 | 91 |
5 |
1c |
4c |
5c |
3 | 88 |
6 |
1d |
4d |
5d |
2.5 | 93 |
7 |
1d |
4e |
5e |
2.5 | 90 |
8 |
1d |
4f |
5f |
3 | 94 |
aAll reactions were carried out at 100 °C by using N-substituted 4-bromo-azaindoles 1 (1.0 mmol), amines (1.2 mmol), Cs2CO3 (1.5 mmol), Pd2(dba)3 (5 mol %), Xantphos (10 mol %), and 2 mL of dioxane. bYields reported are isolated yields. cNR: no reaction. dDesulfonation reaction takes place.
Our continuous efforts to develop synthetic methods for the formation of C–N bonds by coupling of N-protected 7-azaindoles 1 with amino acids or esters result in the development of interesting intermediates in our own medicinal chemistry program based on 7-azaindole. Large molecular architectures designed by cross-coupling strategies with the introduction of an amino acid functionality on 7-azaindole, result in new scaffolding. N-aryl-amino acids are reported as important synthetic intermediates and structural motifs for various drug-development programs by various medicinal and process-research chemists. Therefore, transition metal-catalyzed coupling of amino acids and its derivatives finds popularity in various coupling protocols [58]. A copper(I) iodide catalyzed coupling reaction of haloindoles with α-amino acids was reported by Ishikawa et al. [59].
Indole and azaindole moieties functionalized with amino acid ester scaffold are believed to be important synthetic intermediates and structural components of various medicinal and pharmaceutical candidates. The coupling of N-methyl-4-bromo-7-azaindole (1c) with D-alanine methyl ester 6b was chosen as the model reaction to test the feasibility of the palladium-assisted coupling reaction of 7-azaindole and amino acids. The experimental results are summarized in Table 5. In our initial endeavor the coupling of N-methyl-4-bromo-7-azaindole (1c) with D-alanine (6a) resulted in only a trace amount of product 7a with Xantphos (L1) as a ligand (Table 5, entry 1). Other bidentate aryl phosphine ligands L2 and L3 did not result in any product formation (Table 5, entries 2 and 3). The tertiary phosphine ligand PCy3 (L4) was ineffective in the arylation of N-methyl-4-bromo-7-azaindole (1c) with D-alanine (6a) (Table 5, entry 4). It is believed that the coordination of the central metal of the oxidative addition complex with the carboxyl functionality of the amino acid scaffold retained the Pd–N bond, making the 7-azaindole–Pd–N complexes too stable for reductive elimination [58]. As can be seen from Table 5, the reaction of N-methyl-4-bromo-7-azaindole (1c) with D-alanine methyl ester (6b) occurred rapidly with Pd2(dba)3 as a catalyst, Xantphos (L1) as ligand, and Cs2CO3 as base in dioxane at 100 °C in a short reaction time of 1 h (Table 5, entry 5). When K2CO3 was used as a base with Pd2(dba)3 as a catalyst, and Xantphos (L1) as a ligand, 85% of the product conversion was observed in 3 h (Table 5, entry 6). The other palladium catalyst Pd(OAc)2 results in poor yields of the product (Table 5, entry 13–19). Coupling of N-methyl-4-bromo-7-azaindole (1c) with D-alanine methyl ester (6b) by using SPhos (L2) as a ligand results in low product yield ~14% (Table 5, entry 10). When the bulkier ligand XPhos (L3) was used as a ligand, with Pd2(dba)3 as palladium source, and Cs2CO3 as base, a trace amount of product was formed after 6 h (Table 5, entry 11). On conducting the experiment with Pd(OAc)2 as catalyst and using the same ligand L3, no product formation was observed even after 24 h (Table 5, entry 18). The tertiary phosphine ligand PCy3 (L4) was found to be ineffective when treated with N-methyl-4-bromo-7-azaindole (1c) and D-alanine methyl ester (6b) (Table 5, entry 19). These results indicate that increasing the steric hindrance of the ligands promoted the reductive elimination step during the C–N-bond-forming step [58]. All the coupling reactions of amino acid esters were performed in dioxane as the solvent. Finally, Cs2CO3 as base (Table 5, entry 5) was found to be more effective than stronger bases such as NaOt-Bu, KOH and potassium phosphates (Table 5, entries 7–9).
Table 5: Optimization of the coupling reaction of 1c with D-alanine methyl ester (6b).a
|
||||||
Entry | Pd catalyst (5 mol %) | Amino acid (ester) 6 | Ln | Base | Time (h) | Yield (%)b |
---|---|---|---|---|---|---|
1 | Pd2(dba)3 | 6a | L1 | Cs2CO3 | 24 | tracesc |
2 | Pd2(dba)3 | 6a | L2 | Cs2CO3 | 24 | 0 |
3 | Pd2(dba)3 | 6a | L3 | Cs2CO3 | 24 | 0 |
4 | Pd2(dba)3 | 6a | L4 | Cs2CO3 | 24 | 0 |
5 | Pd2(dba)3 | 6b | L1 | Cs2CO3 | 1 | 93 |
6 | Pd2(dba)3 | 6b | L1 | K2CO3 | 3 | 85 |
7 | Pd2(dba)3 | 6b | L1 | NaOt-Bu | 3 | 44 |
8 | Pd2(dba)3 | 6b | L1 | KOH | 3 | 33 |
9 | Pd2(dba)3 | 6b | L1 | K3PO4 | 3 | 12 |
10 | Pd2(dba)3 | 6b | L2 | Cs2CO3 | 6 | 14 |
11 | Pd2(dba)3 | 6b | L3 | Cs2CO3 | 6 | traces |
12 | Pd2(dba)3 | 6b | L4 | Cs2CO3 | 24 | 0 |
13 | Pd(OAc)2 | 6b | L1 | Cs2CO3 | 24 | 20 |
14 | Pd(OAc)2 | 6b | L1 | K2CO3 | 24 | 15 |
15 | Pd(OAc)2 | 6b | L1 | NaOt-Bu | 24 | 23 |
16 | Pd(OAc)2 | 6b | L1 | K3PO4 | 24 | 20 |
17 | Pd(OAc)2 | 6b | L2 | Cs2CO3 | 24 | 18 |
18 | Pd(OAc)2 | 6b | L3 | Cs2CO3 | 24 | 0 |
19 | Pd(OAc)2 | 6b | L4 | Cs2CO3 | 24 | 0 |
aReaction conditions: N-methyl-4-bromo-7-azaindole (1c) (1.0 mmol), amino acid (ester) (1.2 mmol), base (3.0 mmol), palladium catalyst (5 mol %), ligand (10 mol %), and 2 mL of dioxane, 100 °C, 1–24 h. bYields reported are isolated yields. cTrace amount of product obtained by cross coupling of 1c with 6a.
With a viable coupling procedure in hand, attention was turned to the generality of the process and couplings of structurally diverse amino acid building blocks. Results summarized in Table 6 show that the optimized conditions described proved to be general for the coupling with a wide variety of amino acid building blocks. As can be seen from Table 6, the catalytic system works well with diversified amino acid building blocks. Coupling of N-methyl-4-bromo-7-azaindole (1c) with D-alanine methyl ester (6b) resulted in good yield of the product 7b in a short reaction time (Table 6, entry 2). The chiral purity of the product was determined by chiral HPLC using Chiral Pak AD-H column. Amino acids without extra coordinating groups gave good coupling yields (Table 6, entries 3, 6 and 7). Coupling of L-serine(O-t-Bu)-OMe (6d) with 1c resulted in moderate yield of the product in 3 h (Table 6, entry 4). The catalytic system developed by us for the coupling of amino acid esters with N-protected 7-azaindoles was ineffective for L-proline (6f), L-serine (6g), and L-glutamic acid (6h) (Table 6, entries 8–10). This may be ascribed to the fact that these amino acids contain more heteroatoms that bind to the central palladium atom and enhance the stability of the 7-azaindole–Pd–N complexes, making them too stable for reductive elimination.
Table 6: C–N-bond-formation cross coupling of N-protected 4-bromo-7-azaindoles 1 with amino acid (esters) 6.
|
||||||
Entry | 7-Azaindole 1 | Amino acid (ester) 6 | Product 7a | Time (h) | Yield (%)b | ee (%)d |
---|---|---|---|---|---|---|
1 |
1c |
6a |
7a |
2 | traces | – |
2 |
1c |
6b |
7b |
2 | 70 | 98.79 |
3 |
1c |
6c |
7c |
2 | 72 | – |
4 |
1c |
6d |
7d |
3 | 65 | 95.48 |
5 |
1d |
6b |
7e |
2 | 71 | 98.91 |
6 |
1d |
6c |
7f |
2.1 | 72 | – |
7 |
1d |
6e |
7g |
2 | 70 | – |
8 |
1c |
6f |
– | 5 | 0 | – |
9 |
1c |
6g |
– | 5 | 0 | – |
10 |
1c |
6h |
– | 5 | 0 | – |
aAll reactions were carried out at 100 °C. N-substituted 4-bromo-azaindoles 1c or 1d (1.0 mmol), amino acid (esters) (1.2 mmol), Cs2CO3 (3.0 mmol), Pd2(dba)3 (5 mol %) and Xantphos (10 mol %) were used for all the reactions. bYields reported are isolated yields. cDesulfonation reaction takes place. dee was determined by chiral HPLC.
After successful demonstration of the C–N-bond-formation reaction of 4-bromo-7-azaindole derivatives with amides, amines and amino acid esters, we wanted to expand the scope of the reaction towards C–O-bond formation. Until today no general method has been described for the C–O-bond-formation reaction of 4-halo-azaindole with phenols or alcohols. Most of the literature reports described on C–O-bond-formation reactions are limited to aryl halides and phenols or alcohols only [36,60-63]. Functionalization of 4-substituted-7-azaindole scaffolds with 4-amino-2-fluorophenol was reported to be ineffective upon heating in the presence of a strong base such as KOt-Bu [35]. In addition, the N-oxide derivative of 4-substituted 7-azaindole fails to provide the desired product under similar conditions [48]. Further, on utilizing palladium or copper-mediated cross-coupling reactions of N-protected amino-2-fluorophenol with 4-chloro- or 4-bromo-1H-pyrrolo[2,3-b]pyridine, the desired diaryl ether could not be isolated in acceptable yield [5,35]. To select the best reaction conditions for C–O-bond formation, we envisaged the synthesis of an activated 7-azaindole building block that could be coupled with phenols. To select the best coupling conditions for C–O bond formation, the coupling of 4-bromo-1-methy-1H-pyrrolo[2,3-b]pyridine (1c) with m-cresol (8a) was selected as a model reaction to find the suitable ligands (Scheme 1), palladium catalysts, bases and organic solvents. The experimental findings are summarized in Table 7. The coupling of 1c with 8a by using a combination of Pd(OAc)2, Xantphos (L1) and K2CO3 in dioxane at 100 °C in 10 h of time provided 70% of the desired diaryl ether 9a (Table 7, entry 3). The reaction rate is slow, i.e., when run for 3 h at 100 °C, only 30% product was obtained (Table 7, entry 2). But upon continuous heating for 7 h we observed 70% (Table 7, entry 3) of the expected product. Interestingly, usage of Pd2(dba)3 resulted in poor yields of the product (Table 7, entries 5 and 6). In most of the cases we observed decomposition of the Pd2(dba)3 reagent. In comparison to the conditions described for the amines and amides, a much longer reaction time was required for the C–O-bond formation when treated with phenols. K2CO3 was found to be a suitable base for the C–O-bond formation under the experimental conditions we studied. When Cs2CO3 was used as base, settling of the base was observed even under heating and stirring of the reaction mixture at 100 °C. The probable reason may be that Cs2CO3 is much heavier than K2CO3 and tends to settle in the bottom of the reaction vessel or reactor when run on a larger scale, causing improper mixing of the heterogeneous mixture.
Table 7: Optimization of the coupling reaction of N-methyl-4-bromo-7-azaindole (1c) with m-cresol (8a).a
|
||||||
Entry | Pd catalyst (5 mol %) | Ln | Base | Solvent | Time (h) | Yield (%)b |
---|---|---|---|---|---|---|
1 | Pd(OAc)2 | L1 | Cs2CO3 | dioxane | 5 | 20 |
2 | Pd(OAc)2 | L1 | K2CO3 | dioxane | 3 | 30 |
3 | Pd(OAc)2 | L1 | K2CO3 | dioxane | 10 | 70 |
4 | Pd(OAc)2 | L1 | K2CO3 | THF | 10 | 50 |
5 | Pd2(dba)3 | L1 | Cs2CO3 | dioxane | 3 | 10 |
6 | Pd2(dba)3 | L1 | K2CO3 | dioxane | 10 | 32 |
7 | Pd(OAc)2 | L2 | Cs2CO3 | dioxane | 24 | 45 |
7 | Pd(OAc)2 | L3 | Cs2CO3 | dioxane | 24 | 61 |
9 | Pd(OAc)2 | L1 | K2CO3 | dioxane | 12 | 68 |
10 | Pd(OAc)2 | L1 | K2CO3 | dioxane | 24 | 65 |
aReaction conditions: N-methyl-4-bromo-7-azaindole (1c) (1.0 mmol), m-cresol (1.2 mmol), base (3.0 mmol), palladium catalyst (5 mol %), ligand (10 mol %), and 2 mL of dioxane, 100 °C, 3–24 h. bYields reported are isolated yields.
With a viable coupling procedure in hand, attention was turned to the generality of the process and couplings of structurally diverse phenols. Results are summarized in Table 8. The C–O-bond formation was established with good yields with phenol derivatives and 1-naphthol (Table 8, entries 1–3). Moreover, the outcome of the reaction strongly depended on the electronic character of the appropriate phenol (Table 8). The more-electron-rich nucleophiles 8a, 8b furnished the desired ethers 9a and 9b in good yields. Further studies are in progress in our laboratory to investigate different substrate scope and mechanistic aspects of the C–O-bond-forming reaction.
Table 8: C–O-bond-formation cross coupling of N-methyl-4-bromo-7-azaindole (1c) with phenols 9a–9c.
|
|||||
Entry | 7-Azaindole 1 | Phenol 8 | Product 9a | Time (h) | Yield (%)b |
---|---|---|---|---|---|
1 |
1c |
8a |
9a |
10 | 70 |
2 |
1c |
8b |
9b |
8 | 85 |
3 |
1c |
8c |
9c |
11 | 72 |
aAll reactions were carried out at 100 °C in a dried sealed Schlenk tube by using N-methyl-4-bromo-7-azaindole (1c) (1.0 mmol), phenol (1.2 mmol), K2CO3 (1.5 mmol), Pd(OAc)2 (5 mol %), Xantphos (10 mol %) and 2 mL of dioxane. bYields reported are isolated yields.
Conclusion
In conclusion, we have developed the best coupling conditions for C–N-bond formation of N-substituted 4-bromo-7-azaindoles with amides, amines, and amino acid esters and demonstrated well for the synthesis of various N-substituted 7-azaindole compounds, which are very difficult to synthesize otherwise. The combination of Xantphos, Cs2CO3 and dioxane was found to be crucial for all the C–N cross-coupling reactions. However, different Pd-catalyst precursors were used for different amines/amides and amino acid esters. We have enhanced the methodology towards the C–O-bond formation with various phenols, which is very difficult to achieve. K2CO3 was found to be better for C–O cross-coupling reactions. This protocol provides a nice alternative for the synthesis of N-substituted 7-azaindole derivatives, which exist extensively in natural products and pharmaceuticals. This is the first report on coupling of amides, amino acid esters and phenols with N-substituted 4-bromo-7-azaindole. Hence, we feel that our methodology will serve as an excellent tool in medicinal chemistry, organic synthesis and process research worldwide.
Supporting Information
Supporting information, containing all experimental details and analytical data of all new compounds given in this article as well as their 1H, 13C NMR spectra and HRMS data, is provided.
Supporting Information File 1: Experimental procedures, analytical data and NMR spectra. | ||
Format: PDF | Size: 2.2 MB | Download |
References
-
Zhao, S.-B.; Wang, S. Chem. Soc. Rev. 2010, 39, 3142–3156. doi:10.1039/c001897j
Return to citation in text: [1] [2] -
Popowycz, F.; Routier, S.; Joseph, B.; Mérour, J.-Y. Tetrahedron 2007, 63, 1031–1064. doi:10.1016/j.tet.2006.09.067
Return to citation in text: [1] -
Song, J. J.; Reeves, J. T.; Gallou, F.; Tan, Z.; Yee, N. K.; Senanayake, C. H. Chem. Soc. Rev. 2007, 36, 1120–1132. doi:10.1039/b607868k
Return to citation in text: [1] -
Schlummer, B.; Scholz, U. Adv. Synth. Catal. 2004, 346, 1599–1626. doi:10.1002/adsc.200404216
Return to citation in text: [1] -
Caldwell, J. J.; Cheung, K.-W.; Collins, I. Tetrahedron Lett. 2007, 48, 1527–1529. doi:10.1016/j.tetlet.2007.01.003
Return to citation in text: [1] [2] [3] [4] [5] [6] -
Schneller, S. W.; Luo, J.-K. J. Org. Chem. 1980, 45, 4045–4048. doi:10.1021/jo01308a021
Return to citation in text: [1] [2] [3] -
Girgis, N. S.; Larson, S. B.; Robins, R. K.; Cottam, H. B. J. Heterocycl. Chem. 1989, 26, 317–325. doi:10.1002/jhet.5570260210
Return to citation in text: [1] [2] [3] [4] [5] -
Guillard, J.; Decrop, M.; Gallay, N.; Espanel, C.; Boissier, E.; Herault, O.; Viaud-Massuard, M.-C. Bioorg. Med. Chem. Lett. 2007, 17, 1934–1937. doi:10.1016/j.bmcl.2007.01.033
Return to citation in text: [1] [2] -
Busacca, C. A.; Fandrick, D. R.; Song, J. J.; Senanayake, C. H. Adv. Synth. Catal. 2011, 353, 1825–1864. doi:10.1002/adsc.201100488
Return to citation in text: [1] -
Merour, J.-Y.; Joseph, B. Curr. Org. Chem. 2001, 5, 471–506. doi:10.2174/1385272013375427
Return to citation in text: [1] -
Buckingham, J. Dictionary of Natural Products; University Press: Cambridge, MA, 1994.
Return to citation in text: [1] -
Czarnik, A. W. Acc. Chem. Res. 1996, 29, 112–113. doi:10.1021/ar950256n
Return to citation in text: [1] -
Theil, F. Angew. Chem., Int. Ed. 1999, 38, 2345–2347. doi:10.1002/(SICI)1521-3773(19990816)38:16<2345::AID-ANIE2345>3.0.CO;2-5
Return to citation in text: [1] -
Sawyer, J. S. Tetrahedron 2000, 56, 5045–5065. doi:10.1016/S0040-4020(00)00257-X
Return to citation in text: [1] -
Ley, S. V.; Thomas, A. W. Angew. Chem., Int. Ed. 2003, 42, 5400–5449. doi:10.1002/anie.200300594
Return to citation in text: [1] -
Cristau, P.; Vors, J.-P.; Zhu, J. Tetrahedron 2003, 59, 7859–7870. doi:10.1016/j.tet.2003.08.031
Return to citation in text: [1] -
Muci, A. R.; Buchwald, S. L. Top. Curr. Chem. 2002, 219, 131–209. doi:10.1007/3-540-45313-X_5
Return to citation in text: [1] -
Yin, J.; Buchwald, S. L. Org. Lett. 2000, 2, 1101–1104. doi:10.1021/ol005654r
Return to citation in text: [1] -
Fors, B. P.; Krattiger, P.; Strieter, E.; Buchwald, S. L. Org. Lett. 2008, 10, 3505–3508. doi:10.1021/ol801285g
Return to citation in text: [1] -
Wolfe, J. P.; Tomori, H.; Sadighi, J. P.; Yin, J.; Buchwald, S. L. J. Org. Chem. 2000, 65, 1158–1174. doi:10.1021/jo991699y
Return to citation in text: [1] -
Sadig, J. E. R.; Willis, M. C. Synthesis 2011, 1–22. doi:10.1055/s-0030-1258294
Return to citation in text: [1] -
Hooper, M. W.; Utsunomiya, M.; Hartwig, J. F. J. Org. Chem. 2003, 68, 2861–2873. doi:10.1021/jo0266339
Return to citation in text: [1] -
Peng, Z.-H.; Journet, M.; Humphrey, G. Org. Lett. 2006, 8, 395–398. doi:10.1021/ol052578p
Return to citation in text: [1] -
Chen, W.; Li, J.; Fang, D.; Feng, C.; Zhang, C. Org. Lett. 2008, 10, 4565–4568. doi:10.1021/ol801730g
Return to citation in text: [1] -
Zhang, H.; Cai, Q.; Ma, D. J. Org. Chem. 2005, 70, 5164–5173. doi:10.1021/jo0504464
Return to citation in text: [1] -
Fors, B. P.; Dooleweerdt, K.; Zeng, Q.; Buchwald, S. L. Tetrahedron 2009, 65, 6576–6583. doi:10.1016/j.tet.2009.04.096
Return to citation in text: [1] -
Hartwig, J. F. Acc. Chem. Res. 2008, 41, 1534–1544. doi:10.1021/ar800098p
Return to citation in text: [1] -
Buchwald, S. L.; Mauger, C.; Mignani, G.; Scholz, U. Adv. Synth. Catal. 2006, 348, 23–39. doi:10.1002/adsc.200505158
Return to citation in text: [1] -
Messaoudi, S.; Audisio, D.; Brion, J.-D.; Alami, M. Tetrahedron 2007, 63, 10202–10210. doi:10.1016/j.tet.2007.07.085
Return to citation in text: [1] -
Vimolratana, M.; Simard, J. L.; Brown, S. P. Tetrahedron Lett. 2011, 52, 1020–1022. doi:10.1016/j.tetlet.2010.12.088
Return to citation in text: [1] -
Yao, P.-Y.; Zhang, Y.; Hsung, R. P.; Zhao, K. Org. Lett. 2008, 10, 4275–4278. doi:10.1021/ol801711p
Return to citation in text: [1] -
Schwarz, N.; Pews-Davtyan, A.; Alex, K.; Tillack, A.; Beller, M. Synthesis 2007, 3722–3730. doi:10.1055/s-2007-990819
Return to citation in text: [1] -
Benarous, R.; Barbey-Treve, S.; Paris, J.-M.; Berrut, S.; Berlioz-Torrent, C.; Emiliani, S. Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-HIV agents. WO Patent WO2010066847, June 17, 2010.
Return to citation in text: [1] -
Sergeev, A. G.; Artamkina, G. A.; Velezheva, V. S.; Fedorova, I. N.; Beletskava, I. P. Russ. J. Org. Chem. 2005, 41, 860–874. doi:10.1007/s11178-005-0257-0
Return to citation in text: [1] -
Edmondson, S. D.; Mastracchio, A.; Parmee, E. R. Org. Lett. 2000, 2, 1109–1112. doi:10.1021/ol000031z
Return to citation in text: [1] [2] [3] -
Gowrisankar, S.; Sergeev, A. G.; Anbarasan, P.; Spannenberg, A.; Neumann, H.; Beller, M. J. Am. Chem. Soc. 2010, 132, 11592–11598. doi:10.1021/ja103248d
Return to citation in text: [1] [2] -
Thutewohl, M.; Schirok, H.; Bennabi, S.; Figueroa-Pérez, S. Synthesis 2006, 629–632. doi:10.1055/s-2006-926310
Return to citation in text: [1] -
Figueroa-Pérez, S.; Bennabi, S.; Schirok, H.; Thutewohi, M. Tetrahedron Lett. 2006, 47, 2069–2072. doi:10.1016/j.tetlet.2006.01.143
Return to citation in text: [1] -
Henderson, J. L.; McDermott, S. M.; Buchwald, S. L. Org. Lett. 2010, 12, 4438–4441. doi:10.1021/ol101928m
Return to citation in text: [1] [2] -
Blake, J.; Gunawardana, I. W.; Le Huerou, Y.; Mohr, P. J.; Wallace, E. M.; Wang, B. Pyrrolopyridines as kinase inhibitors. WO Patent WO2009089352, July 16, 2009.
Return to citation in text: [1] -
Toshihiro, H.; Hiroko, N.; Jun, T. Novel compounds. U.S. Patent Application US20100016307A1, Jan 21, 2010.
Return to citation in text: [1] -
Surasani, R.; Kalita, D.; Rao, A. V. D.; Yarbagi, Y.; Chandrasekhar, K. B. J. Fluorine Chem. 2012, 135, 91–96. doi:10.1016/j.jfluchem.2011.09.005
Return to citation in text: [1] -
Layek, M.; Gajare, V.; Kalita, D.; Islam, A.; Mukkanti, K.; Pal, M. Tetrahedron 2009, 65, 4814–4819. doi:10.1016/j.tet.2009.04.054
Return to citation in text: [1] -
Layek, M.; Gajare, V.; Kalita, D.; Islam, A.; Mukkanti, K.; Pal, M. Tetrahedron Lett. 2009, 50, 3867–3871. doi:10.1016/j.tetlet.2009.04.048
Return to citation in text: [1] -
Layek, M.; Rao, A. V. D.; Gajare, V.; Kalita, D.; Barange, D. K.; Islam, A.; Mukkanti, K.; Pal, M. Tetrahedron Lett. 2009, 50, 4878–4881. doi:10.1016/j.tetlet.2009.06.041
Return to citation in text: [1] -
Layek, M.; Lakshmi, U.; Kalita, D.; Barange, D. K.; Islam, A.; Mukkanti, K.; Pal, M. Beilstein J. Org. Chem. 2009, 5, No. 46. doi:10.3762/bjoc.5.46
Return to citation in text: [1] -
Thibault, C.; L'Heureux, A.; Bhide, R. S.; Ruel, R. Org. Lett. 2003, 5, 5023–5025. doi:10.1021/ol036030z
Return to citation in text: [1] -
Kühler, T. C.; Swanson, M.; Shcherbuchin, V.; Larsson, H.; Mellgård, B.; Sjöström, J.-E. J. Med. Chem. 1998, 41, 1777–1788. doi:10.1021/jm970165r
Return to citation in text: [1] [2] -
Antilla, J. C.; Klapars, A.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 11684–11688. doi:10.1021/ja027433h
Return to citation in text: [1] -
Old, D. W.; Harris, M. C.; Buchwald, S. L. Org. Lett. 2000, 2, 1403–1406. doi:10.1021/ol005728z
Return to citation in text: [1] -
Kranenburg, M.; van der Burgt, Y. E. M.; Kamer, P. C. J.; van Leeuwen, P. W. N. M.; Goubitz, K.; Fraanje, J. Organometallics 1995, 14, 3081–3089. doi:10.1021/om00006a057
Return to citation in text: [1] -
Guari, Y.; van Es, D. S.; Reek, J. N. H.; Kamer, P. C. J.; van Leeuwen, P. W. N. M. Tetrahedron Lett. 1999, 40, 3789–3790. doi:10.1016/S0040-4039(99)00527-4
Return to citation in text: [1] -
Wagaw, S.; Yang, B. H.; Buchwald, S. L. J. Am. Chem. Soc. 1999, 121, 10251–10263. doi:10.1021/ja992077x
Return to citation in text: [1] -
Imbriglio, J. E.; DiRocco, D.; Raghavan, S.; Ball, R. G.; Tsou, N.; Mosley, R. T.; Tata, J. R.; Colletti, S. L. Tetrahedron Lett. 2008, 49, 4897–4900. doi:10.1016/j.tetlet.2008.05.148
Return to citation in text: [1] -
Vandromme, L.; Legraverend, M.; Kreimerman, S.; Lozach, O.; Meijer, L.; Grierson, D. S. Bioorg. Med. Chem. 2007, 15, 130–141. doi:10.1016/j.bmc.2006.10.003
Return to citation in text: [1] -
Piguel, S.; Legraverend, M. J. Org. Chem. 2007, 72, 7026–7029. doi:10.1021/jo071196p
Return to citation in text: [1] -
Chaulet, C.; Croix, C.; Basset, J.; Pujol, M.-D.; Viaud-Massuard, M.-C. Synlett 2010, 1481–1484. doi:10.1055/s-0029-1219918
Return to citation in text: [1] -
Ma, F.; Xie, X.; Ding, L.; Gao, J.; Zhang, Z. Tetrahedron 2011, 67, 9405–9410. doi:10.1016/j.tet.2011.09.109
And references cited therein.
Return to citation in text: [1] [2] [3] -
Kurokawa, M.; Nakanishi, W.; Ishikawa, T. Heterocycles 2007, 71, 847–854. doi:10.3987/COM-06-10985
Return to citation in text: [1] -
Wolter, M.; Nordmann, G.; Job, G. E.; Buchwald, S. L. Org. Lett. 2002, 4, 973–976. doi:10.1021/ol025548k
Return to citation in text: [1] -
Kuwabe, S.-i.; Torraca, K. E.; Buchwald, S. L. J. Am. Chem. Soc. 2001, 123, 12202–12206. doi:10.1021/ja012046d
Return to citation in text: [1] -
Torraca, K. E.; Huang, X.; Parrish, C. A.; Buchwald, S. L. J. Am. Chem. Soc. 2001, 123, 10770–10771. doi:10.1021/ja016863p
Return to citation in text: [1] -
Parrish, C. A.; Buchwald, S. L. J. Org. Chem. 2001, 66, 2498–2500. doi:10.1021/jo001426z
Return to citation in text: [1]
48. | Kühler, T. C.; Swanson, M.; Shcherbuchin, V.; Larsson, H.; Mellgård, B.; Sjöström, J.-E. J. Med. Chem. 1998, 41, 1777–1788. doi:10.1021/jm970165r |
5. | Caldwell, J. J.; Cheung, K.-W.; Collins, I. Tetrahedron Lett. 2007, 48, 1527–1529. doi:10.1016/j.tetlet.2007.01.003 |
35. | Edmondson, S. D.; Mastracchio, A.; Parmee, E. R. Org. Lett. 2000, 2, 1109–1112. doi:10.1021/ol000031z |
1. | Zhao, S.-B.; Wang, S. Chem. Soc. Rev. 2010, 39, 3142–3156. doi:10.1039/c001897j |
2. | Popowycz, F.; Routier, S.; Joseph, B.; Mérour, J.-Y. Tetrahedron 2007, 63, 1031–1064. doi:10.1016/j.tet.2006.09.067 |
3. | Song, J. J.; Reeves, J. T.; Gallou, F.; Tan, Z.; Yee, N. K.; Senanayake, C. H. Chem. Soc. Rev. 2007, 36, 1120–1132. doi:10.1039/b607868k |
4. | Schlummer, B.; Scholz, U. Adv. Synth. Catal. 2004, 346, 1599–1626. doi:10.1002/adsc.200404216 |
11. | Buckingham, J. Dictionary of Natural Products; University Press: Cambridge, MA, 1994. |
12. | Czarnik, A. W. Acc. Chem. Res. 1996, 29, 112–113. doi:10.1021/ar950256n |
13. | Theil, F. Angew. Chem., Int. Ed. 1999, 38, 2345–2347. doi:10.1002/(SICI)1521-3773(19990816)38:16<2345::AID-ANIE2345>3.0.CO;2-5 |
14. | Sawyer, J. S. Tetrahedron 2000, 56, 5045–5065. doi:10.1016/S0040-4020(00)00257-X |
15. | Ley, S. V.; Thomas, A. W. Angew. Chem., Int. Ed. 2003, 42, 5400–5449. doi:10.1002/anie.200300594 |
16. | Cristau, P.; Vors, J.-P.; Zhu, J. Tetrahedron 2003, 59, 7859–7870. doi:10.1016/j.tet.2003.08.031 |
17. | Muci, A. R.; Buchwald, S. L. Top. Curr. Chem. 2002, 219, 131–209. doi:10.1007/3-540-45313-X_5 |
1. | Zhao, S.-B.; Wang, S. Chem. Soc. Rev. 2010, 39, 3142–3156. doi:10.1039/c001897j |
48. | Kühler, T. C.; Swanson, M.; Shcherbuchin, V.; Larsson, H.; Mellgård, B.; Sjöström, J.-E. J. Med. Chem. 1998, 41, 1777–1788. doi:10.1021/jm970165r |
5. | Caldwell, J. J.; Cheung, K.-W.; Collins, I. Tetrahedron Lett. 2007, 48, 1527–1529. doi:10.1016/j.tetlet.2007.01.003 |
6. | Schneller, S. W.; Luo, J.-K. J. Org. Chem. 1980, 45, 4045–4048. doi:10.1021/jo01308a021 |
7. | Girgis, N. S.; Larson, S. B.; Robins, R. K.; Cottam, H. B. J. Heterocycl. Chem. 1989, 26, 317–325. doi:10.1002/jhet.5570260210 |
8. | Guillard, J.; Decrop, M.; Gallay, N.; Espanel, C.; Boissier, E.; Herault, O.; Viaud-Massuard, M.-C. Bioorg. Med. Chem. Lett. 2007, 17, 1934–1937. doi:10.1016/j.bmcl.2007.01.033 |
10. | Merour, J.-Y.; Joseph, B. Curr. Org. Chem. 2001, 5, 471–506. doi:10.2174/1385272013375427 |
49. | Antilla, J. C.; Klapars, A.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 11684–11688. doi:10.1021/ja027433h |
50. | Old, D. W.; Harris, M. C.; Buchwald, S. L. Org. Lett. 2000, 2, 1403–1406. doi:10.1021/ol005728z |
9. | Busacca, C. A.; Fandrick, D. R.; Song, J. J.; Senanayake, C. H. Adv. Synth. Catal. 2011, 353, 1825–1864. doi:10.1002/adsc.201100488 |
42. | Surasani, R.; Kalita, D.; Rao, A. V. D.; Yarbagi, Y.; Chandrasekhar, K. B. J. Fluorine Chem. 2012, 135, 91–96. doi:10.1016/j.jfluchem.2011.09.005 |
43. | Layek, M.; Gajare, V.; Kalita, D.; Islam, A.; Mukkanti, K.; Pal, M. Tetrahedron 2009, 65, 4814–4819. doi:10.1016/j.tet.2009.04.054 |
44. | Layek, M.; Gajare, V.; Kalita, D.; Islam, A.; Mukkanti, K.; Pal, M. Tetrahedron Lett. 2009, 50, 3867–3871. doi:10.1016/j.tetlet.2009.04.048 |
45. | Layek, M.; Rao, A. V. D.; Gajare, V.; Kalita, D.; Barange, D. K.; Islam, A.; Mukkanti, K.; Pal, M. Tetrahedron Lett. 2009, 50, 4878–4881. doi:10.1016/j.tetlet.2009.06.041 |
46. | Layek, M.; Lakshmi, U.; Kalita, D.; Barange, D. K.; Islam, A.; Mukkanti, K.; Pal, M. Beilstein J. Org. Chem. 2009, 5, No. 46. doi:10.3762/bjoc.5.46 |
5. | Caldwell, J. J.; Cheung, K.-W.; Collins, I. Tetrahedron Lett. 2007, 48, 1527–1529. doi:10.1016/j.tetlet.2007.01.003 |
6. | Schneller, S. W.; Luo, J.-K. J. Org. Chem. 1980, 45, 4045–4048. doi:10.1021/jo01308a021 |
7. | Girgis, N. S.; Larson, S. B.; Robins, R. K.; Cottam, H. B. J. Heterocycl. Chem. 1989, 26, 317–325. doi:10.1002/jhet.5570260210 |
8. | Guillard, J.; Decrop, M.; Gallay, N.; Espanel, C.; Boissier, E.; Herault, O.; Viaud-Massuard, M.-C. Bioorg. Med. Chem. Lett. 2007, 17, 1934–1937. doi:10.1016/j.bmcl.2007.01.033 |
47. | Thibault, C.; L'Heureux, A.; Bhide, R. S.; Ruel, R. Org. Lett. 2003, 5, 5023–5025. doi:10.1021/ol036030z |
40. | Blake, J.; Gunawardana, I. W.; Le Huerou, Y.; Mohr, P. J.; Wallace, E. M.; Wang, B. Pyrrolopyridines as kinase inhibitors. WO Patent WO2009089352, July 16, 2009. |
41. | Toshihiro, H.; Hiroko, N.; Jun, T. Novel compounds. U.S. Patent Application US20100016307A1, Jan 21, 2010. |
7. | Girgis, N. S.; Larson, S. B.; Robins, R. K.; Cottam, H. B. J. Heterocycl. Chem. 1989, 26, 317–325. doi:10.1002/jhet.5570260210 |
37. | Thutewohl, M.; Schirok, H.; Bennabi, S.; Figueroa-Pérez, S. Synthesis 2006, 629–632. doi:10.1055/s-2006-926310 |
38. | Figueroa-Pérez, S.; Bennabi, S.; Schirok, H.; Thutewohi, M. Tetrahedron Lett. 2006, 47, 2069–2072. doi:10.1016/j.tetlet.2006.01.143 |
39. | Henderson, J. L.; McDermott, S. M.; Buchwald, S. L. Org. Lett. 2010, 12, 4438–4441. doi:10.1021/ol101928m |
39. | Henderson, J. L.; McDermott, S. M.; Buchwald, S. L. Org. Lett. 2010, 12, 4438–4441. doi:10.1021/ol101928m |
5. | Caldwell, J. J.; Cheung, K.-W.; Collins, I. Tetrahedron Lett. 2007, 48, 1527–1529. doi:10.1016/j.tetlet.2007.01.003 |
7. | Girgis, N. S.; Larson, S. B.; Robins, R. K.; Cottam, H. B. J. Heterocycl. Chem. 1989, 26, 317–325. doi:10.1002/jhet.5570260210 |
31. | Yao, P.-Y.; Zhang, Y.; Hsung, R. P.; Zhao, K. Org. Lett. 2008, 10, 4275–4278. doi:10.1021/ol801711p |
32. | Schwarz, N.; Pews-Davtyan, A.; Alex, K.; Tillack, A.; Beller, M. Synthesis 2007, 3722–3730. doi:10.1055/s-2007-990819 |
33. | Benarous, R.; Barbey-Treve, S.; Paris, J.-M.; Berrut, S.; Berlioz-Torrent, C.; Emiliani, S. Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-HIV agents. WO Patent WO2010066847, June 17, 2010. |
34. | Sergeev, A. G.; Artamkina, G. A.; Velezheva, V. S.; Fedorova, I. N.; Beletskava, I. P. Russ. J. Org. Chem. 2005, 41, 860–874. doi:10.1007/s11178-005-0257-0 |
35. | Edmondson, S. D.; Mastracchio, A.; Parmee, E. R. Org. Lett. 2000, 2, 1109–1112. doi:10.1021/ol000031z |
36. | Gowrisankar, S.; Sergeev, A. G.; Anbarasan, P.; Spannenberg, A.; Neumann, H.; Beller, M. J. Am. Chem. Soc. 2010, 132, 11592–11598. doi:10.1021/ja103248d |
18. | Yin, J.; Buchwald, S. L. Org. Lett. 2000, 2, 1101–1104. doi:10.1021/ol005654r |
19. | Fors, B. P.; Krattiger, P.; Strieter, E.; Buchwald, S. L. Org. Lett. 2008, 10, 3505–3508. doi:10.1021/ol801285g |
20. | Wolfe, J. P.; Tomori, H.; Sadighi, J. P.; Yin, J.; Buchwald, S. L. J. Org. Chem. 2000, 65, 1158–1174. doi:10.1021/jo991699y |
21. | Sadig, J. E. R.; Willis, M. C. Synthesis 2011, 1–22. doi:10.1055/s-0030-1258294 |
22. | Hooper, M. W.; Utsunomiya, M.; Hartwig, J. F. J. Org. Chem. 2003, 68, 2861–2873. doi:10.1021/jo0266339 |
23. | Peng, Z.-H.; Journet, M.; Humphrey, G. Org. Lett. 2006, 8, 395–398. doi:10.1021/ol052578p |
24. | Chen, W.; Li, J.; Fang, D.; Feng, C.; Zhang, C. Org. Lett. 2008, 10, 4565–4568. doi:10.1021/ol801730g |
25. | Zhang, H.; Cai, Q.; Ma, D. J. Org. Chem. 2005, 70, 5164–5173. doi:10.1021/jo0504464 |
26. | Fors, B. P.; Dooleweerdt, K.; Zeng, Q.; Buchwald, S. L. Tetrahedron 2009, 65, 6576–6583. doi:10.1016/j.tet.2009.04.096 |
27. | Hartwig, J. F. Acc. Chem. Res. 2008, 41, 1534–1544. doi:10.1021/ar800098p |
28. | Buchwald, S. L.; Mauger, C.; Mignani, G.; Scholz, U. Adv. Synth. Catal. 2006, 348, 23–39. doi:10.1002/adsc.200505158 |
29. | Messaoudi, S.; Audisio, D.; Brion, J.-D.; Alami, M. Tetrahedron 2007, 63, 10202–10210. doi:10.1016/j.tet.2007.07.085 |
30. | Vimolratana, M.; Simard, J. L.; Brown, S. P. Tetrahedron Lett. 2011, 52, 1020–1022. doi:10.1016/j.tetlet.2010.12.088 |
5. | Caldwell, J. J.; Cheung, K.-W.; Collins, I. Tetrahedron Lett. 2007, 48, 1527–1529. doi:10.1016/j.tetlet.2007.01.003 |
7. | Girgis, N. S.; Larson, S. B.; Robins, R. K.; Cottam, H. B. J. Heterocycl. Chem. 1989, 26, 317–325. doi:10.1002/jhet.5570260210 |
57. | Chaulet, C.; Croix, C.; Basset, J.; Pujol, M.-D.; Viaud-Massuard, M.-C. Synlett 2010, 1481–1484. doi:10.1055/s-0029-1219918 |
51. | Kranenburg, M.; van der Burgt, Y. E. M.; Kamer, P. C. J.; van Leeuwen, P. W. N. M.; Goubitz, K.; Fraanje, J. Organometallics 1995, 14, 3081–3089. doi:10.1021/om00006a057 |
52. | Guari, Y.; van Es, D. S.; Reek, J. N. H.; Kamer, P. C. J.; van Leeuwen, P. W. N. M. Tetrahedron Lett. 1999, 40, 3789–3790. doi:10.1016/S0040-4039(99)00527-4 |
53. | Wagaw, S.; Yang, B. H.; Buchwald, S. L. J. Am. Chem. Soc. 1999, 121, 10251–10263. doi:10.1021/ja992077x |
54. | Imbriglio, J. E.; DiRocco, D.; Raghavan, S.; Ball, R. G.; Tsou, N.; Mosley, R. T.; Tata, J. R.; Colletti, S. L. Tetrahedron Lett. 2008, 49, 4897–4900. doi:10.1016/j.tetlet.2008.05.148 |
55. | Vandromme, L.; Legraverend, M.; Kreimerman, S.; Lozach, O.; Meijer, L.; Grierson, D. S. Bioorg. Med. Chem. 2007, 15, 130–141. doi:10.1016/j.bmc.2006.10.003 |
56. | Piguel, S.; Legraverend, M. J. Org. Chem. 2007, 72, 7026–7029. doi:10.1021/jo071196p |
36. | Gowrisankar, S.; Sergeev, A. G.; Anbarasan, P.; Spannenberg, A.; Neumann, H.; Beller, M. J. Am. Chem. Soc. 2010, 132, 11592–11598. doi:10.1021/ja103248d |
60. | Wolter, M.; Nordmann, G.; Job, G. E.; Buchwald, S. L. Org. Lett. 2002, 4, 973–976. doi:10.1021/ol025548k |
61. | Kuwabe, S.-i.; Torraca, K. E.; Buchwald, S. L. J. Am. Chem. Soc. 2001, 123, 12202–12206. doi:10.1021/ja012046d |
62. | Torraca, K. E.; Huang, X.; Parrish, C. A.; Buchwald, S. L. J. Am. Chem. Soc. 2001, 123, 10770–10771. doi:10.1021/ja016863p |
63. | Parrish, C. A.; Buchwald, S. L. J. Org. Chem. 2001, 66, 2498–2500. doi:10.1021/jo001426z |
35. | Edmondson, S. D.; Mastracchio, A.; Parmee, E. R. Org. Lett. 2000, 2, 1109–1112. doi:10.1021/ol000031z |
58. |
Ma, F.; Xie, X.; Ding, L.; Gao, J.; Zhang, Z. Tetrahedron 2011, 67, 9405–9410. doi:10.1016/j.tet.2011.09.109
And references cited therein. |
58. |
Ma, F.; Xie, X.; Ding, L.; Gao, J.; Zhang, Z. Tetrahedron 2011, 67, 9405–9410. doi:10.1016/j.tet.2011.09.109
And references cited therein. |
58. |
Ma, F.; Xie, X.; Ding, L.; Gao, J.; Zhang, Z. Tetrahedron 2011, 67, 9405–9410. doi:10.1016/j.tet.2011.09.109
And references cited therein. |
59. | Kurokawa, M.; Nakanishi, W.; Ishikawa, T. Heterocycles 2007, 71, 847–854. doi:10.3987/COM-06-10985 |
5. | Caldwell, J. J.; Cheung, K.-W.; Collins, I. Tetrahedron Lett. 2007, 48, 1527–1529. doi:10.1016/j.tetlet.2007.01.003 |
6. | Schneller, S. W.; Luo, J.-K. J. Org. Chem. 1980, 45, 4045–4048. doi:10.1021/jo01308a021 |
© 2012 Surasani et al; licensee Beilstein-Institut.
This is an Open Access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (http://www.beilstein-journals.org/bjoc)